<DOC>
	<DOCNO>NCT02728167</DOCNO>
	<brief_summary>The purpose study evaluate whether HIFU-assisted liver resection ( HIFU-AR ) result reduce blood loss compare standard liver resection patient LM.This prospective , monocentric , randomize ( 1:1 ratio ) , comparative , open-label Phase II study .</brief_summary>
	<brief_title>Efficacy HIFU-AR Blood Loss Reduction Patients With Liver Metastases Requiring Hepatectomy</brief_title>
	<detailed_description />
	<mesh_term>Neoplasm Metastasis</mesh_term>
	<mesh_term>Neoplasms , Second Primary</mesh_term>
	<mesh_term>Liver Neoplasms</mesh_term>
	<mesh_term>Liver Extracts</mesh_term>
	<criteria>Age ≥ 18 year day consent study . Patients liver metastasis require hepatectomy ≥ 2 segment . ECOG PS ≤ 1 . Adequate bone marrow liver function baseline define : Platelet count ≥ 100 x 109/l , hemoglobin ≥ 9 g/dl ) , Total bilirubin ≤ 1.5 x ULN , AST ALT ≤ 5 x ULN . Recovered prior antineoplasic treatmentrelated toxicity ( grade &lt; 2 persistent treatmentrelated toxicity per CTCAE v4 accept ) . Willingness followup visit . Covered medical insurance . Signed date informed consent document indicate patient inform aspect trial prior enrolment . Patients previously undergone major hepatic surgery ( i.e . 3 liver segment ) biliary major surgery . Patient cirrhosis sinusoidal obstruction syndrome portal hypertension . Pregnant woman ( woman childbearing potential require negative pregnancy test within 72 hour prior inclusion ) . A positive urine test must confirm serum pregnancy test .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2016</verification_date>
	<keyword>Hepatectomy</keyword>
	<keyword>Liver metastasis</keyword>
	<keyword>High-Intensity Focused Ultrasound</keyword>
	<keyword>Liver metastasis ( LM ) require surgery</keyword>
</DOC>